Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chemokine (C-C motif) receptor 3 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0167 | 0.4015 | 0.4288 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.0322 | 0.8733 | 0.8733 |
Trichomonas vaginalis | phospholipase A-2-activating protein, putative | 0.0036 | 0 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0364 | 1 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.0322 | 0.8733 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.0322 | 0.8733 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0148 | 0.343 | 0.358 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.0322 | 0.8733 | 0.8733 |
Echinococcus granulosus | intestinal type alkaline phosphatase | 0.0322 | 0.8733 | 0.8733 |
Schistosoma mansoni | hypothetical protein | 0.0085 | 0.1517 | 0.1263 |
Echinococcus granulosus | alkaline phosphatase | 0.0322 | 0.8733 | 0.8733 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.1144 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.008 | 0.135 | 0.1062 |
Toxoplasma gondii | PUL domain-containing protein | 0.0036 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0125 | 0.2713 | 0.2712 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.0322 | 0.8733 | 0.8733 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0165 | 0.3955 | 0.3955 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0165 | 0.3955 | 0.3955 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0125 | 0.2713 | 0.2713 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0148 | 0.343 | 0.343 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.0322 | 0.8733 | 0.8733 |
Schistosoma mansoni | thyroid hormone receptor | 0.0148 | 0.343 | 0.358 |
Leishmania major | hypothetical protein, conserved | 0.0036 | 0 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0159 | 0.3749 | 0.3966 |
Brugia malayi | Cache domain containing protein | 0.0073 | 0.1144 | 1 |
Plasmodium falciparum | polyubiquitin binding protein, putative | 0.0036 | 0 | 0.5 |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.0322 | 0.8733 | 0.8733 |
Schistosoma mansoni | serine-rich repeat protein | 0.0085 | 0.1517 | 0.1263 |
Echinococcus multilocularis | alkaline phosphatase | 0.0322 | 0.8733 | 0.8733 |
Trypanosoma cruzi | WD domain, G-beta repeat/PFU (PLAA family ubiquitin binding), putative | 0.0036 | 0 | 0.5 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0125 | 0.2713 | 0.2713 |
Trypanosoma cruzi | WD domain, G-beta repeat/PFU (PLAA family ubiquitin binding), putative | 0.0036 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 15 nM | Evaluated for inhibition of eotaxin-induced [Ca2+] release in human eosinophils | ChEMBL. | 15664858 |
IC50 (binding) | = 0.6 nM | Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells | ChEMBL. | 15664858 |
IC50 (binding) | = 0.6 nM | Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells | ChEMBL. | 15664858 |
Inhibition (functional) | = 24 % | Percentage inhibition of eotaxin-induced human eosinophil chemotaxis was determined at 30 nM concentration | ChEMBL. | 15664858 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.